This inventor holds 40 USPTO granted patents and 27 published patent applications, plus 6 CIPO patents and 10 EPO patents, primarily in RNAi Compositions. Top assignees: Alnylam Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc., Novartis Ag. Active years: 2012-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Weston, MA (US) (2015)
- Cambridge, MA (US) (2012 - 2022)
- Acton, MA (US) (2016 - 2024)
Company Filing History:
31 out of 466 
5 out of 102 
3 out of 3,978 
Years Active: 2012-2026
Areas of Expertise:
Title: Satyanarayana Kuchimanchi: Innovator in RNAi Therapeutics
Introduction
Satyanarayana Kuchimanchi is a prominent inventor based in Acton, Massachusetts, known for his significant contributions to the field of RNA interference (RNAi) and therapeutic innovations. With an impressive portfolio of 36 patents, he has made a substantial impact in addressing critical health challenges, particularly in treating diseases linked to heat shock factor 1 (HSF1) and complement component C5.
Latest Patents
Among his latest patents is a groundbreaking innovation titled "Organic compositions to treat HSF1-related diseases," which outlines methods for treating conditions such as cancer and viral diseases through the use of a therapeutically effective RNAi agent targeting HSF. Additionally, he has patented "Complement component C5 iRNA compositions and methods of use thereof," which describes RNAi compositions designed to target the complement component C5 gene, offering new avenues for treating diseases associated with this component, such as paroxysmal nocturnal hemoglobinuria.
Career Highlights
Satyanarayana has built a distinguished career working with renowned organizations such as Alnylam Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc. His work has not only led to numerous patents but also inspired innovation in RNA-based therapies, paving the way for new treatments that could revolutionize patient care.
Collaborations
He has collaborated with esteemed professionals in the field, including his coworkers Martin A. Maier and Stuart Milstein, contributing to a rich culture of innovation and shared knowledge that enhances the research and development process.
Conclusion
Satyanarayana Kuchimanchi stands out as a leading inventor whose work in RNAi therapeutics is shaping the future of medical treatments. His extensive patent portfolio and collaborative efforts exemplify his commitment to advancing science and medicine, presenting new hope for patients facing serious health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile